622405-00-9

Basic information

• Product Name: 2-{[(1RS,2SR,3SR)-2-allyl-1,3-dimethylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-hydroxypentanoate
• Synonyms: 2-{[(1RS,2SR,3SR)-2-allyl-1,3-dimethylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-hydroxypentanoate
• CAS NO: 622405-00-9
• Molecular Weight: 418.574
• Mol File: 622405-00-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-{[(1RS,2SR,3SR)-2-allyl-1,3-dimethylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-hydroxypentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-{[(1RS,2SR,3SR)-2-allyl-1,3-dimethylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-hydroxypentanoate(622405-00-9)
• EPA Substance Registry System: 2-{[(1RS,2SR,3SR)-2-allyl-1,3-dimethylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-hydroxypentanoate(622405-00-9)

Safety Data

• Hazardous Substances Data: 622405-00-9(Hazardous Substances Data)

Upstream product

• 620615-98-7 (3R,4R)-4-(benzyloxy)-3-{[(tert-butyl)dimethylsilyl]oxy}pentanoic acid 
• 620615-97-6 (4R,5R)-5-(benzyloxy)-4-{[(tert-butyl)dimethylsilyl]oxy}pent-1-ene 
• 620616-21-9 (3R,4R)-4-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-pentanal 
• 89104-01-8 (2R,3R)-2-(benzyloxy)-5-hexen-3-ol 
• 53346-05-7 (R)-2-benzyloxypropanal 
• 61674-94-0 trans-3-Methyl-2-(2-propenyl)cyclohexanone 
• 38019-50-0 2-allyl-cyclohex-2-enone 
• 622404-99-3 2-{[(1RS,2SR,3SR)-2-allyl-1,3-dimethylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-{[(tert-butyl)dimethylsilyl]oxy}pentanoate 

Downstream Products

• 620616-19-5 (7R,10E,12aS,13S,16aR)-7-[(1R)-1-(benzyloxy)ethyl]-2,3,6,7,12a,13,14,15,16,16a-decahydro-13,16a-dimethyl-5H-1,4,8-benzotrioxacyclotetradecine-5,9(12H)-dione 
• 620616-20-8 (7R,10E,12aR,13R,16aS)-7-[(1R)-1-(benzyloxy)ethyl]-2,3,6,7,12a,13,14,15,16,16a-decahydro-13,16a-dimethyl-5H-1,4,8-benzotrioxacyclotetradecine-5,9(12H)-dione 

Relevant articles and documents

Synthesis and conformational analysis of macrocyclic dilactones mimicking the pharmacophore of aplysiatoxin

A small number of macrocyclic dilactones of type 3, i.e., 9, 10, 11, and epi-11, comprising a 3,4-dihydroxypentanoic acid unit, the pharmacophore of aplysiatoxin, and a conformationally preorganized ω-hydroxynonanoic acid unit were synthesized. Conformati